Liquidia Technologies (NASDAQ:LQDA) Insider Jason Adair Sells 26,057 Shares

Key Points

• Insider Jason Adair sold 26,057 shares of Liquidia Technologies at an average price of $27.86, totaling around $725,948, resulting in a 13.22% decrease in his ownership.
• Liquidia Technologies recently reported a quarterly revenue of $8.84 million, significantly exceeding analysts' expectations and marking a 141.5% increase year-over-year, despite an EPS loss of ($0.49).
• Analysts have upgraded Liquidia's stock ratings, with Raymond James raising the target price from $33.00 to $41.00, reflecting strong buy sentiments following positive market performance.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Jason Adair sold 26,057 shares of the stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $27.86, for a total value of $725,948.02. Following the completion of the sale, the insider directly owned 171,029 shares of the company's stock, valued at $4,764,867.94. The trade was a 13.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Jason Adair also recently made the following trade(s):

• On Tuesday, September 2nd, Jason Adair sold 451 shares of Liquidia Technologies stock. The shares were sold at an average price of $29.05, for a total value of $13,101.55.
• On Tuesday, September 2nd, Jason Adair sold 451 shares of Liquidia Technologies stock. The shares were sold at an average price of $29.05, for a total value of $13,101.55.
• On Monday, July 28th, Jason Adair sold 454 shares of Liquidia Technologies stock. The shares were sold at an average price of $19.54, for a total value of $8,871.16.
• On Monday, July 14th, Jason Adair sold 2,576 shares of Liquidia Technologies stock. The shares were sold at an average price of $14.28, for a total value of $36,785.28.

Liquidia Technologies Stock Performance

Shares of NASDAQ:LQDA traded up $0.90 during trading on Tuesday, reaching $28.58. The company had a trading volume of 3,973,236 shares, compared to its average volume of 1,817,921. The firm has a market capitalization of $2.46 billion, a price-to-earnings ratio of -16.81 and a beta of 0.22. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The stock's fifty day moving average price is $19.18 and its 200 day moving average price is $16.44. Liquidia Technologies, Inc. has a fifty-two week low of $8.75 and a fifty-two week high of $29.28.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). The company had revenue of $8.84 million during the quarter, compared to analyst estimates of $3.90 million. Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. Liquidia Technologies's quarterly revenue was up 141.5% compared to the same quarter last year. As a group, equities research analysts predict that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on LQDA. Raymond James Financial boosted their target price on Liquidia Technologies from $33.00 to $41.00 and gave the company a "strong-buy" rating in a report on Wednesday, August 13th. Jefferies Financial Group assumed coverage on Liquidia Technologies in a report on Friday, August 15th. They issued a "buy" rating and a $43.00 target price on the stock. Scotiabank raised their price target on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday, May 28th. Wall Street Zen raised Liquidia Technologies from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Finally, Wells Fargo & Company upped their price objective on Liquidia Technologies from $25.00 to $31.00 and gave the stock an "overweight" rating in a report on Wednesday, August 13th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Liquidia Technologies currently has a consensus rating of "Buy" and a consensus target price of $32.11.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of LQDA. NewEdge Advisors LLC acquired a new stake in shares of Liquidia Technologies in the 2nd quarter worth approximately $25,000. Hurley Capital LLC acquired a new stake in shares of Liquidia Technologies in the 1st quarter worth approximately $32,000. GAMMA Investing LLC grew its holdings in shares of Liquidia Technologies by 65.6% in the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock worth $44,000 after acquiring an additional 1,173 shares during the period. Quarry LP acquired a new stake in shares of Liquidia Technologies in the 1st quarter worth approximately $79,000. Finally, Steward Partners Investment Advisory LLC grew its holdings in shares of Liquidia Technologies by 24.0% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock worth $77,000 after acquiring an additional 1,200 shares during the period. Institutional investors and hedge funds own 64.54% of the company's stock.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.